Skip to content

A study on the psychological trajectory of post-traumatic growth and the application of expressive writing in young hematopoietic stem cell transplantation patients

A study on the psychological trajectory of post-traumatic growth and the application of expressive writing in young hematopoietic stem cell transplantation patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092088
Enrollment
Unknown
Registered
2024-11-08
Start date
2023-01-03
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic stem cell transplantation

Interventions

control group:Routine nursing
intervention group: expressive writing programs

Sponsors

Department of Hematology, The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1.15 to 39 years old (according to the National Cancer Institute standards, patients who are first diagnosed with cancer between the ages of 15 and 39 years old are defined as young cancer patients); 2. After pathological diagnosis, it was confirmed as hematological system tumor; 3. A transplant plan has been developed; 4. no language communication barriers; 5. Have the ability to write expression.

Exclusion criteria

Exclusion criteria: 1. Consciousness disorders, mental patients; 2. People with hearing impairment and expression impairment; 3. Illiterates, too low education level to understand the content of the questionnaire; 4. Those currently undergoing psychotherapy or participating in similar trials.

Design outcomes

Secondary

MeasureTime frame
Connor-Davidson Resilience Scale 10; Fear of Cancer Recurrence Scale;

Primary

MeasureTime frame
cognitive emotion regulation questionnaire;Post-traumatic Growth Inventory;

Countries

China

Contacts

Public ContactShen Zhiying

Department of Hematology, Third Xiangya Hospital, Central South University

1561958851@qq.com+86 155 2641 9980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026